Asciminib
Generic name: Asciminib
Brand names: Scemblix
Dosage form: oral tablet (20 mg; 40 mg)
Drug class:
BCR-ABL tyrosine kinase inhibitors
Usage of Asciminib
Asciminib is used in adults to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (CML).
Asciminib is usually given after other treatments have failed.
Asciminib may also be used for purposes not listed in this medication guide.
Asciminib side effects
Get emergency medical help if you have signs of an allergic reaction: hives, rash; feeling dizzy or faint; fever; fast heartbeat; difficult breathing; swelling of your face, lips, tongue, or throat.
Asciminib may cause serious side effects. Call your doctor at once if you have:
Common side effects of asciminib may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Asciminib
Tell your doctor if you have ever had:
You may need to have a negative pregnancy test before starting this treatment.
It may be harder for you to get pregnant while you are using asciminib.
Asciminib may harm an unborn baby. Use effective birth control while you are using this medicine, and for at least 1 week after your last dose. Tell your doctor right away if you become pregnant.
You should not breastfeed while using this medicine, and for at least 1 week after your last dose.
Relate drugs
How to use Asciminib
Usual Adult Dose for Chronic Myelogenous Leukemia:
Philadelphia chromosome-positive chronic myeloid leukemia I chronic phase (Ph+ CML-CP)Ph+ CML-CP Previously Treated with 2 or More TKIs (tyrosine kinase inhibitors):Recommended dose: 80 mg orally once a day OR 40 mg orally every 12 hours Duration of therapy: Continue as long as clinical benefit is observed or until unacceptable toxicity occurs Ph+ CML-CP with the T315I Mutation:Recommended dose:: 200 mg orally every 12 hoursComments:-This drug is approved under accelerated approval based on major molecular response; continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials -For recommended dosage modifications for the management of adverse reactions; see Dose Adjustments. Uses: -Treatment of Ph+ CML in CP, previously treated with 2 or more tyrosine kinase inhibitors (TKIs) -Treatment of Ph+ CML in CP with the T315I mutation
Warnings
Use only as directed. Tell your doctor if you use other medicines or have other medical conditions or allergies.
What other drugs will affect Asciminib
Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.
Many drugs can affect asciminib. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all other medicines you use.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions